Press Release: GMO’s Nebo Surpasses $1Billion in Platform Assets One Year After Launch (September 2023)
Press Release: GMO’s Nebo Surpasses $1Billion in Platform Assets One Year After Launch (September 2023)
Press Release: GMO’s Nebo Surpasses $1Billion in Platform Assets One Year After Launch (September 2023)
Press Release: GMO’s Nebo Surpasses $1Billion in Platform Assets One Year After Launch (September 2023)
Nebo is born of nearly a decade of GMO research focused on solving for optimal portfolio construction that seeks to minimize shortfall risk, further enhanced by a three-year process of user-led development with a cohort of early adopters. These RIAs have provided valuable feedback and input, ensuring that Nebo meets the needs of fiduciary advisors.
In 2013, we started thinking about the portfolio construction problem for individual investors. At the time, Ben Inker, Head of Asset Allocation, had a meeting with one of our corporate clients who ran a defined contribution plan.
The client asked for GMO’s thoughts on how to construct a glide path. With that, Ben, Martin Tarlie, and others at GMO began the research that was to become Nebo.
In 2019, we built an early-stage Nebo prototype and embarked on a listening campaign with RIAs across North America.
In September 2022, GMO officially launched Nebo – A New Technology-driven Custom Goals-based Investing Platform for RIAs.
New GMO RIA Platform Wins Wealth Award
The innovative Nebo platform has won the WealthManagement.com 2022 Industry Disruptor award.
Dr. Nitzberg is a member of GMO’s Board of Directors and the acting Nebo CEO. An AI scientist, entrepreneur, and consultant to industry and government and a seasoned organizational leader, Dr. Nitzberg has built companies and products in the areas of computer vision, machine learning, financial portfolio optimization, workflow efficiencies, online commerce, development aid data capture and analytics, and film and theatre. Dr. Nitzberg is also the co-founder of Smartleaf Inc., and has been its Senior Advisor since June, 2017. He began studying AI as a stowaway student at MIT in the AI wave of the early 1980’s, and wrote his PhD in Computer Vision and Human Perception at Harvard University.
Dr. Tarlie is a member of GMO’s Asset Allocation team and serves as the Nebo product lead. Prior to re-joining GMO in 2018, he was a managing director at QMA. He previously worked on GMO’s Global Equity team from 2007 to 2014. Prior to that he worked at Breakwater Trading and at Marlin Capital Corp as a fundamental equity analyst and the director of research. Dr. Tarlie earned his bachelor's degree in physics from the University of Michigan, his PhD in theoretical condensed matter physics from the University of Illinois at Urbana-Champaign, and his MBA from the University of Chicago. He was also a postdoctoral research fellow at the James Franck Institute at the University of Chicago and is a CFA charterholder.
Mr. Kadnar is a Member of GMO’s Asset Allocation Team, a partner of the firm and serves as the Nebo sales lead. Prior to joining GMO in 2004, he was an investment specialist and consultant relations manager at Putnam Investments. Previously, he served as in-house counsel for LPL Financial Services and as a senior associate at Melick & Porter, LLP. Mr. Kadnar earned his bachelor's degree from Boston College majoring in Finance and Philosophy and a JD from St. Louis University School of Law. He is a CFA charterholder.
Mr. Finnegan is engaged in client relations and business development for GMO’s Global Client Relations team and serves as Nebo marketing lead. Previously at GMO, he was a member of the Shareholder Services team. Prior to joining GMO in 2015, he worked for a hedge fund administrator as a senior investor services associate. Previously, he worked as a client service specialist at Pioneer Investments. Mr. Finnegan earned his bachelor's degree in Economics from Lafayette College. He is a CAIA and a CFA charterholder.
Mr. Inker is co-head of GMO’s Asset Allocation team, a member of the GMO Board of Directors, and a partner of the firm. He joined GMO in 1992 following the completion of his bachelor's degree in Economics from Yale University. In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities. He is a CFA charterholder.
Mr. Montier is a member of GMO’s Asset Allocation team and a partner of the firm. Prior to joining GMO in 2009, he was co-head of GlobalStrategy at Société Générale. Mr. Montier is the author of several books including “Behavioural Investing: A Practitioner’s Guide to Applying Behavioural Finance”; “Value Investing: Tools and Techniques for Intelligent Investment”; and “The Little Book of Behavioural Investing. ”Mr. Montier is a visiting fellow at the University of Durham and a fellow of the Royal Society of Arts. He holds a BA in Economics from Portsmouth University and an MSc in Economics from Warwick University.
Dr. Nitzberg is a member of GMO’s Board of Directors and the acting Nebo CEO. An AI scientist, entrepreneur, and consultant to industry and government and a seasoned organizational leader, Dr. Nitzberg has built companies and products in the areas of computer vision, machine learning, financial portfolio optimization, workflow efficiencies, online commerce, development aid data capture and analytics, and film and theatre. Dr. Nitzberg is also the co-founder of Smartleaf Inc., and has been its Senior Advisor since June, 2017. He began studying AI as a stowaway student at MIT in the AI wave of the early 1980’s, and wrote his PhD in Computer Vision and Human Perception at Harvard University.
Dr. Tarlie is a member of GMO’s Asset Allocation team and serves as the Nebo product lead. Prior to re-joining GMO in 2018, he was a managing director at QMA. He previously worked on GMO’s Global Equity team from 2007 to 2014. Prior to that he worked at Breakwater Trading and at Marlin Capital Corp as a fundamental equity analyst and the director of research. Dr. Tarlie earned his bachelor's degree in physics from the University of Michigan, his PhD in theoretical condensed matter physics from the University of Illinois at Urbana-Champaign, and his MBA from the University of Chicago. He was also a postdoctoral research fellow at the James Franck Institute at the University of Chicago and is a CFA charterholder.
Mr. Kadnar is a Member of GMO’s Asset Allocation Team, a partner of the firm and serves as the Nebo sales lead. Prior to joining GMO in 2004, he was an investment specialist and consultant relations manager at Putnam Investments. Previously, he served as in-house counsel for LPL Financial Services and as a senior associate at Melick & Porter, LLP. Mr. Kadnar earned his bachelor's degree from Boston College majoring in Finance and Philosophy and a JD from St. Louis University School of Law. He is a CFA charterholder.
Mr. Finnegan is engaged in client relations and business development for GMO’s Global Client Relations team and serves as Nebo marketing lead. Previously at GMO, he was a member of the Shareholder Services team. Prior to joining GMO in 2015, he worked for a hedge fund administrator as a senior investor services associate. Previously, he worked as a client service specialist at Pioneer Investments. Mr. Finnegan earned his bachelor's degree in Economics from Lafayette College. He is a CAIA and a CFA charterholder.
Mr. Inker is co-head of GMO’s Asset Allocation team, a member of the GMO Board of Directors, and a partner of the firm. He joined GMO in 1992 following the completion of his bachelor's degree in Economics from Yale University. In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities. He is a CFA charterholder.
Mr. Montier is a member of GMO’s Asset Allocation team and a partner of the firm. Prior to joining GMO in 2009, he was co-head of GlobalStrategy at Société Générale. Mr. Montier is the author of several books including “Behavioural Investing: A Practitioner’s Guide to Applying Behavioural Finance”; “Value Investing: Tools and Techniques for Intelligent Investment”; and “The Little Book of Behavioural Investing. ”Mr. Montier is a visiting fellow at the University of Durham and a fellow of the Royal Society of Arts. He holds a BA in Economics from Portsmouth University and an MSc in Economics from Warwick University.
For more than 40 years, GMO has partnered with a broad range of sophisticated institutions, financial intermediaries, and families to provide the investment expertise they need to meet their goals and fulfill their missions.
GMO is comprised of a collection of investment teams with focused specialties. All are grounded in a long-term, valuation-based investment philosophy – an approach we believe provides the best risk-adjusted returns.
GMO partners with an impressive roster of sophisticated clients worldwide, delivering innovative investment solutions and tailored client service.
We believe ESG factors can have a meaningful impact on the long-term success of companies and countries, and our investment teams incorporate them where we believe doing so will improve investment results.
Read about notable GMO investment strategies, research, people, and press coverage.
53 State Street
33rd Floor
Boston, MA 02109
Telephone: +1.617.330.7500
2150 Shattuck Avenue
Suite 900
Berkeley, CA 94704
Telephone: +1.510.649.6030